Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Raras (18)

2023

  1. Live Cell Adhesion, Migration, and Invasion Assays

    Methods in Molecular Biology (Humana Press Inc.), pp. 313-329

  2. Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity

    The Journal of clinical investigation, Vol. 133, Núm. 10

2022

  1. Cardiac fibroblasts display endurance to ischemia, high ROS control and elevated respiration regulated by the JAK2/STAT pathway

    FEBS Journal, Vol. 289, Núm. 9, pp. 2540-2561

  2. M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors

    British Journal of Cancer

2021

  1. Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 4, pp. 544-563

2018

  1. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy

    EMBO Molecular Medicine, Vol. 10, Núm. 8

2017

  1. Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance

    Aging Cell, Vol. 16, Núm. 6, pp. 1404-1413

  2. Multilayer OMIC Data in medullary thyroid carcinoma identifies the STAT3 pathway as a potential therapeutic target in RETM918T Tumors

    Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1334-1345

2016

  1. Targeted activation of CREB in reactive astrocytes is neuroprotective in focal acute cortical injury

    GLIA, Vol. 64, Núm. 5, pp. 853-874

2015

  1. Deregulation of purine metabolism in Alzheimer's disease

    Neurobiology of Aging, Vol. 36, Núm. 1, pp. 68-80

  2. Neuroinflammatory signals in alzheimer disease and APP/PS1 transgenic mice: Correlations with plaques, tangles, and oligomeric species

    Journal of Neuropathology and Experimental Neurology, Vol. 74, Núm. 4, pp. 319-344

2013

  1. Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions

    American Journal of Pathology, Vol. 182, Núm. 2, pp. 350-362

2012

  1. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: A paradigm for multifactorial neurodegenerative diseases?

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1822, Núm. 9, pp. 1475-1488

  2. Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma

    Oncogene, Vol. 31, Núm. 35, pp. 3961-3972

2011

  1. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy

    Annals of Neurology, Vol. 70, Núm. 1, pp. 84-92

  2. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy

    Antioxidants and Redox Signaling, Vol. 15, Núm. 8, pp. 2095-2107

2010

  1. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy

    Human Molecular Genetics, Vol. 19, Núm. 10, pp. 2005-2014

2008

  1. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy

    Human Molecular Genetics, Vol. 17, Núm. 12, pp. 1762-1773